A 52-year-old man from Delhi presents to the emergency department with a 3-day history of fever (39.5°C), productive cough with rust-coloured sputum, and pleuritic chest pain. He has a 20-year history of smoking. On examination, he is tachypneic (respiratory rate 28/min), with crackles in the right lower lobe. Chest X-ray shows consolidation in the right lower lobe. Blood cultures are pending. A Gram stain of sputum shows Gram-positive diplococci, and optochin sensitivity testing is positive. Which of the following is the most appropriate initial antibiotic therapy for this patient?

Explanation

## Clinical Diagnosis **Key Point:** The clinical presentation (community-acquired pneumonia with rust-coloured sputum, Gram-positive diplococci, optochin-sensitive) is pathognomonic for *Streptococcus pneumoniae*. ## Why Ceftriaxone Is Correct **High-Yield:** Third-generation cephalosporins (ceftriaxone, cefotaxime) are the empiric agents of choice for community-acquired pneumonia (CAP) caused by *S. pneumoniae* in India, especially when meningitis cannot be excluded clinically [cite:Park 26e Ch 3]. **Clinical Pearl:** Ceftriaxone 2 g IV 12-hourly achieves excellent lung penetration and CSF levels sufficient to cover both meningitis and pneumonia. It is superior to penicillin because: - Covers penicillin-intermediate and penicillin-resistant strains (PIPS/PRSP) - Achieves higher CSF concentrations - Recommended by Indian CAP guidelines as first-line empiric therapy ## Comparison of Options | Agent | Spectrum | CSF Penetration | Resistance Coverage | Use Case | | --- | --- | --- | --- | --- | | **Ceftriaxone** | Gram-positive, Gram-negative | Excellent | PIPS/PRSP | Empiric CAP ± meningitis | | **Penicillin G** | Gram-positive (penicillin-sensitive only) | Moderate | None (obsolete for PRSP) | Penicillin-sensitive *S. pneumoniae* only | | **Vancomycin** | Gram-positive (including MRSA) | Poor | PRSP | Reserved for meningitis or severe allergy | | **Chloramphenicol** | Broad-spectrum | Good | Some PRSP | Rarely used; hepatotoxicity risk | **Warning:** Do NOT use penicillin G monotherapy in the modern era — prevalence of penicillin-resistant *S. pneumoniae* (PRSP) in India is significant, and penicillin does not achieve adequate CSF levels for meningitis. **Mnemonic:** **CAP-CEPH** — Community-Acquired Pneumonia → CEPHalosporin (3rd generation) is empiric choice for *S. pneumoniae*.